Astellas
The Lead Value Evidence role at Astellas is responsible for developing and executing US Medical Value Evidence strategies to support brand success and patient access for assigned products. This position requires a highly experienced Health Economics and Outcomes Research professional to translate insights into actionable value evidence strategies that address the needs of payers, healthcare providers, and other key stakeholders. The role involves leading strategic discussions, delivering high-impact evidence outputs, and collaborating with cross-functional teams to optimize market access outcomes.
Astellas is a global life sciences company headquartered in Tokyo, Japan, committed to turning innovative science into value for patients through transformative therapies. The company operates in more than 70 countries and focuses on disease areas including oncology, ophthalmology, urology, immunology, and women's health. Through its research and development programs, Astellas pioneers new healthcare solutions in areas with high unmet medical need.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Astellas.
8% below the average for this role
HTA, Value & Evidence Senior Manager
Pfizer
Director, HTA, Value & Evidence (HV&E) – Internal Medicine Early Pipeline
Pfizer
Director, HTA, Value & Evidence (HV&E) – Obesity
Pfizer
Senior Manager, HTA, Value and Evidence (HV&E), Rare Disease
Pfizer
Executive Director, Health Economics & Outcomes Research (HEOR)
Travere Therapeutics
US Director, HEOR & RWE
Zealand Pharma